Chordate Medical Holding AB (publ) (STO:CMH)
Sweden
· Delayed Price · Currency is SEK 7.28
-0.42 (-5.45%)
May 30, 2025, 4:45 PM CET
STO:CMH Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2.47 | 2.44 | 1.75 | 0.11 | 2.18 | 3.61 | Upgrade
|
| Revenue Growth (YoY) | 8.63% | 39.85% | 1509.77% | -95.03% | -39.57% | 22.49% | Upgrade
|
| Cost of Revenue | 0.65 | 0.45 | 0.44 | 0.07 | 0.26 | 1.1 | Upgrade
|
| Gross Profit | 1.81 | 1.99 | 1.31 | 0.03 | 1.93 | 2.51 | Upgrade
|
| Selling, General & Admin | 26.91 | 27.16 | 28.49 | 25.5 | 22.58 | 19.47 | Upgrade
|
| Other Operating Expenses | 0.05 | 0.06 | -0.06 | 0.1 | -0.45 | -0.1 | Upgrade
|
| Operating Expenses | 28.97 | 29.43 | 30.88 | 28.06 | 23.67 | 21.93 | Upgrade
|
| Operating Income | -27.15 | -27.45 | -29.57 | -28.02 | -21.74 | -19.42 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0.01 | -0 | -0.02 | -0.34 | Upgrade
|
| Interest & Investment Income | 0.2 | 0.2 | 0.39 | 0.08 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | - | - | - | - | - | Upgrade
|
| Pretax Income | -26.99 | -27.25 | -29.19 | -27.94 | -21.77 | -19.76 | Upgrade
|
| Net Income | -26.99 | -27.25 | -29.19 | -27.94 | -21.77 | -19.76 | Upgrade
|
| Net Income to Common | -26.99 | -27.25 | -29.19 | -27.94 | -21.77 | -19.76 | Upgrade
|
| Shares Outstanding (Basic) | - | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | - | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | 117.08% | 44.62% | 35.51% | 85.53% | 141.61% | Upgrade
|
| EPS (Basic) | - | -27.96 | -65.00 | -90.00 | -95.00 | -160.00 | Upgrade
|
| EPS (Diluted) | - | -27.96 | -65.00 | -90.00 | -95.00 | -160.00 | Upgrade
|
| Free Cash Flow | -25.43 | -25.51 | -27.64 | -25.37 | -20.34 | -17.56 | Upgrade
|
| Free Cash Flow Per Share | - | -26.17 | -61.56 | -81.71 | -88.76 | -142.19 | Upgrade
|
| Gross Margin | 73.50% | 81.40% | 74.94% | 31.39% | 88.18% | 69.60% | Upgrade
|
| Operating Margin | -1101.16% | -1123.43% | -1692.82% | -25824.64% | -995.84% | -537.58% | Upgrade
|
| Profit Margin | -1094.55% | -1115.59% | -1670.79% | -25749.85% | -996.98% | -546.95% | Upgrade
|
| Free Cash Flow Margin | -1031.41% | -1044.20% | -1582.34% | -23377.48% | -931.48% | -486.05% | Upgrade
|
| EBITDA | -26.46 | -26.44 | -28.33 | -26.79 | -20.5 | -18.05 | Upgrade
|
| D&A For EBITDA | 0.7 | 1 | 1.24 | 1.24 | 1.24 | 1.37 | Upgrade
|
| EBIT | -27.15 | -27.45 | -29.57 | -28.02 | -21.74 | -19.42 | Upgrade
|
| Revenue as Reported | 2.5 | 2.47 | 1.92 | 0.16 | 2.68 | 3.86 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.